2024 Annual Meeting | C81 - Headache in Special Populations
| 01:00 PM - 01:15 PM MDT | Introduction |
Headache in Special Populations
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, FÂ鶹´«Ã½Ó³» |
| 01:15 PM - 01:30 PM MDT | Speaker |
Case & Presentation: Headache Special Population—Individuals with Severe Cognitive, Mental, and/or Physical Impairments and the Caregiver
Susan M. Woolner, CPXP |
| 01:30 PM - 01:35 PM MDT | Q&A |
Questions & Answers
Susan M. Woolner, CPXP |
| 01:35 PM - 01:50 PM MDT | Speaker |
Case & Presentation: Headache Special Population: Children
Christina L. Szperka, MD, FÂ鶹´«Ã½Ó³» |
| 01:50 PM - 01:55 PM MDT | Q&A |
Questions & Answers
Christina L. Szperka, MD, FÂ鶹´«Ã½Ó³» |
| 01:55 PM - 02:10 PM MDT | Speaker |
Case & Presentation: Headache Special Population: Rural Populations
David B. Watson, MD, FÂ鶹´«Ã½Ó³» |
| 02:10 PM - 02:15 PM MDT | Q&A |
Questions & Answers
David B. Watson, MD, FÂ鶹´«Ã½Ó³» |
| 02:15 PM - 02:25 PM MDT | Q&A |
Panelists Questions & Answers
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, FÂ鶹´«Ã½Ó³», Susan M. Woolner, CPXP, David B. Watson, MD, FÂ鶹´«Ã½Ó³» |
| 02:25 PM - 02:35 PM MDT | Speaker |
A Brief Exploration of Intersectionality
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, FÂ鶹´«Ã½Ó³» |
| 02:35 PM - 02:55 PM MDT | Discussion |
Final Case Presentation with Audience Participation and Panelist Discussion
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, FÂ鶹´«Ã½Ó³», Susan M. Woolner, CPXP, David B. Watson, MD, FÂ鶹´«Ã½Ó³» |
| 02:55 PM - 03:00 PM MDT | Closing Remarks |
Closing Remarks
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, FÂ鶹´«Ã½Ó³» |
| Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, FÂ鶹´«Ã½Ó³» | Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. Dr. Charleston has or had stock in Mi-Helper Inc..Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Charleston has a non-compensated relationship as a Chair, EDI Advisory Committee (Non-voting Board Member) with American Headache Society that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Susan M. Woolner, CPXP | Ms. Woolner has nothing to disclose. |
| David B. Watson, MD, FÂ鶹´«Ã½Ó³» | Dr. Watson has nothing to disclose. |
| Christina L. Szperka, MD, FÂ鶹´«Ã½Ó³» | The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. The institution of Dr. Szperka has received research support from PCORI. Dr. Szperka has a non-compensated relationship as a Cochair Scientific Committee with American Headache Society that is relevant to Â鶹´«Ã½Ó³» interests or activities. |